183 related articles for article (PubMed ID: 30457036)
1. Ruthenium complex delivery using liposomes to improve bioactivity against HeLa cells via the mitochondrial pathway.
Guo B; Liao C; Fang Y; Li S; Li X; Lu Z; Chen Y
Nanomedicine (Lond); 2018 Nov; 13(22):2851-2866. PubMed ID: 30457036
[TBL] [Abstract][Full Text] [Related]
2. Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.
Zhao Z; Luo Z; Wu Q; Zheng W; Feng Y; Chen T
Dalton Trans; 2014 Dec; 43(45):17017-28. PubMed ID: 25087850
[TBL] [Abstract][Full Text] [Related]
3. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
[TBL] [Abstract][Full Text] [Related]
4. Anticancer activity and mechanism of bis-pyrimidine based dimetallic Ru(II)(η
Bhatti MZ; Ali A; Duong HQ; Chen J; Rahman FU
J Inorg Biochem; 2019 May; 194():52-64. PubMed ID: 30831390
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium(II) polypyridyl complexes induce BEL-7402 cell apoptosis by ROS-mediated mitochondrial pathway.
Jiang GB; Zheng X; Yao JH; Han BJ; Li W; Wang J; Huang HL; Liu YJ
J Inorg Biochem; 2014 Dec; 141():170-179. PubMed ID: 25268891
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of new ruthenium polypyridyl complexes with potent antitumor activity in vitro.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Sep; 220():117132. PubMed ID: 31146211
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium(II) salicylate complexes inducing ROS-mediated apoptosis by targeting thioredoxin reductase.
Chen JC; Zhang Y; Jie XM; She J; Dongye GZ; Zhong Y; Deng YY; Wang J; Guo BY; Chen LM
J Inorg Biochem; 2019 Apr; 193():112-123. PubMed ID: 30711557
[TBL] [Abstract][Full Text] [Related]
8. Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets.
Guedes APM; Mello-Andrade F; Pires WC; de Sousa MAM; da Silva PFF; de Camargo MS; Gemeiner H; Amauri MA; Gomes Cardoso C; de Melo Reis PR; Silveira-Lacerda EP; Batista AA
Metallomics; 2020 Apr; 12(4):547-561. PubMed ID: 32108850
[TBL] [Abstract][Full Text] [Related]
9. Studies of anticancer activity in vivo and in vitro behaviors of liposomes encapsulated iridium(III) complex.
Gu Y; Wen H; Zhang Y; Bai L; Zhou Y; Zhang H; Tian L; Hao J; Liu Y
J Biol Inorg Chem; 2021 Feb; 26(1):109-122. PubMed ID: 33475857
[TBL] [Abstract][Full Text] [Related]
10. Ruthenium(II) polypyridyl complexes: cellular uptake, cell image and apoptosis of HeLa cancer cells induced by double targets.
Yu Q; Liu Y; Xu L; Zheng C; Le F; Qin X; Liu Y; Liu J
Eur J Med Chem; 2014 Jul; 82():82-95. PubMed ID: 24878637
[TBL] [Abstract][Full Text] [Related]
11. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
[TBL] [Abstract][Full Text] [Related]
12. Insights into anticancer activity and mechanism of action of a ruthenium(II) complex in human esophageal squamous carcinoma EC109 cells.
Guo L; Lv G; Qiu L; Yang H; Zhang L; Yu H; Zou M; Lin J
Eur J Pharmacol; 2016 Sep; 786():60-71. PubMed ID: 27262377
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity, apoptosis, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential, and Western blotting analysis of ruthenium(II) complexes.
Lin GJ; Jiang GB; Xie YY; Huang HL; Liang ZH; Liu YJ
J Biol Inorg Chem; 2013 Dec; 18(8):873-82. PubMed ID: 23989405
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Characterization, and Inducing Tumor Cell Apoptosis of Two Ru(II) Complexes Containing Guanidinium as Ligands.
Sun J; Chen WX; Song XD; He SF; Chen JX; Mei J; Zhu XX; Wu T
Anticancer Agents Med Chem; 2018; 18(1):110-120. PubMed ID: 28425859
[TBL] [Abstract][Full Text] [Related]
15. Novel ruthenium(II) triazine complex [Ru(bdpta)(tpy)]
Purushothaman B; Arumugam P; Ju H; Kulsi G; Samson AAS; Song JM
Eur J Med Chem; 2018 Aug; 156():747-759. PubMed ID: 30048924
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex.
Chen Y; Qin MY; Wu JH; Wang L; Chao H; Ji LN; Xu AL
Eur J Med Chem; 2013; 70():120-9. PubMed ID: 24141202
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor activity and mechanism of apoptosis of A549 induced by ruthenium complex.
Sun D; Mou Z; Li N; Zhang W; Wang Y; Yang E; Wang W
J Biol Inorg Chem; 2016 Dec; 21(8):945-956. PubMed ID: 27620172
[TBL] [Abstract][Full Text] [Related]
18. Anticancer cationic ruthenium nanovectors: from rational molecular design to cellular uptake and bioactivity.
Mangiapia G; Vitiello G; Irace C; Santamaria R; Colonna A; Angelico R; Radulescu A; D'Errico G; Montesarchio D; Paduano L
Biomacromolecules; 2013 Aug; 14(8):2549-60. PubMed ID: 23705931
[TBL] [Abstract][Full Text] [Related]
19. A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer.
Shen J; Kim HC; Wolfram J; Mu C; Zhang W; Liu H; Xie Y; Mai J; Zhang H; Li Z; Guevara M; Mao ZW; Shen H
Nano Lett; 2017 May; 17(5):2913-2920. PubMed ID: 28418672
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells.
Du Y; Fu X; Li H; Chen B; Guo Y; Su G; Zhang H; Ning F; Lin Y; Mei W; Chen T
ChemMedChem; 2014 Apr; 9(4):714-8. PubMed ID: 24403015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
